81 related articles for article (PubMed ID: 22906876)
1. Association of promyelocytic leukemia protein with expression of IL-6 and resistance to treatment in multiple myeloma.
Ohgiya D; Matsushita H; Onizuka M; Nakamura N; Amaki J; Aoyama Y; Kawai H; Ogawa Y; Kawada H; Ando K
Acta Haematol; 2012; 128(4):213-22. PubMed ID: 22906876
[TBL] [Abstract][Full Text] [Related]
2. [Expression of promyelocytic leukaemia protein in lung carcinomas and clinical significance thereof].
Zhao ZL; Huang QY; Xu S; Zhang L; Zhao HR
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(47):3362-6. PubMed ID: 17313836
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues.
Gambacorta M; Flenghi L; Fagioli M; Pileri S; Leoncini L; Bigerna B; Pacini R; Tanci LN; Pasqualucci L; Ascani S; Mencarelli A; Liso A; Pelicci PG; Falini B
Am J Pathol; 1996 Dec; 149(6):2023-35. PubMed ID: 8952536
[TBL] [Abstract][Full Text] [Related]
4. Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RAR alpha and RAR alpha-PML assessment in patients who ultimately relapse.
Grimwade D; Howe K; Langabeer S; Burnett A; Goldstone A; Solomon E
Leukemia; 1996 Jan; 10(1):61-6. PubMed ID: 8558940
[TBL] [Abstract][Full Text] [Related]
5. [Research progress in cytoplasmic PML gene functions].
Xu XH; Sun YY; Zhang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):857-60. PubMed ID: 24989309
[TBL] [Abstract][Full Text] [Related]
6. Reverse transcription-polymerase chain reaction for PML-RAR alpha fusion transcripts in acute promyelocytic leukemia and its application to minimal residual leukemia detection.
Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
Leukemia; 1993 Apr; 7(4):544-8. PubMed ID: 8385249
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.
Mologni L; Marchesi E; Nielsen PE; Gambacorti-Passerini C
Cancer Res; 2001 Jul; 61(14):5468-73. PubMed ID: 11454693
[TBL] [Abstract][Full Text] [Related]
8. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
[TBL] [Abstract][Full Text] [Related]
9. The puzzling multiple lives of PML and its role in the genesis of cancer.
Ruggero D; Wang ZG; Pandolfi PP
Bioessays; 2000 Sep; 22(9):827-35. PubMed ID: 10944585
[TBL] [Abstract][Full Text] [Related]
10. PML overexpression inhibits proliferation and promotes the osteogenic differentiation of human mesenchymal stem cells.
Sun J; Fu S; Zhong W; Huang H
Oncol Rep; 2013 Dec; 30(6):2785-94. PubMed ID: 24101171
[TBL] [Abstract][Full Text] [Related]
11. Acute promyelocytic leukemia: from clinic to molecular biology.
Chen SJ; Wang ZY; Chen Z
Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
[TBL] [Abstract][Full Text] [Related]
12. [Progress in researches on the function of PML gene].
Zhou L; Chen G; Shen Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):132-5. PubMed ID: 10751540
[TBL] [Abstract][Full Text] [Related]
13. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA.
Lai HK; Borden KL
Oncogene; 2000 Mar; 19(13):1623-34. PubMed ID: 10763819
[TBL] [Abstract][Full Text] [Related]
14. Concordant down-regulation of proto-oncogene PML and major histocompatibility antigen HLA class I expression in high-grade prostate cancer.
Zhang H; Melamed J; Wei P; Cox K; Frankel W; Bahnson RR; Robinson N; Pyka R; Liu Y; Zheng P
Cancer Immun; 2003 Feb; 3():2. PubMed ID: 12747744
[TBL] [Abstract][Full Text] [Related]
15. Induction of the pro-myelocytic leukaemia gene by type I and type II interferons.
Heuser M; van der Kuip H; Falini B; Peschel C; Huber C; Fischer T
Mediators Inflamm; 1998; 7(5):319-25. PubMed ID: 9883966
[TBL] [Abstract][Full Text] [Related]
16. PML/RAR alpha+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3.
Testa U; Grignani F; Barberi T; Fagioli M; Masciulli R; Ferrucci PF; Seripa D; Camagna A; Alcalay M; Pelicci PG
Cancer Res; 1994 Aug; 54(16):4508-15. PubMed ID: 7519122
[TBL] [Abstract][Full Text] [Related]
17. [The molecular mechanism of PML in inducing apoptosis of bladder cancer cell line].
Li L; He DL; He H; Wang XY; Zhang LL; Luo Y; Nan XY
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1766-9. PubMed ID: 16253165
[TBL] [Abstract][Full Text] [Related]
18. PML expression in soft tissue sarcoma: prognostic and predictive value in alkylating agents/antracycline-based first line therapy.
Vincenzi B; Santini D; Schiavon G; Frezza AM; Silletta M; Crucitti P; Casali P; Dei Tos AP; Rossi S; Rizzo S; Badalamenti G; Tomasino RM; Russo A; Butrynski JE; Tonini G
J Cell Physiol; 2012 Apr; 227(4):1657-62. PubMed ID: 21678421
[TBL] [Abstract][Full Text] [Related]
19. PML protein as a prognostic molecular marker for patients with esophageal squamous cell carcinomas receiving primary surgery.
Yen CC; Tsao YP; Chen PC; Wu YC; Liu JH; Pan CC; Liu CY; Tzeng CH; Chen PM; Chen YJ; Lin CH; Hsu WH
J Surg Oncol; 2011 Jun; 103(8):761-7. PubMed ID: 21240990
[TBL] [Abstract][Full Text] [Related]
20. Promyelocytic leukemia protein-induced growth suppression and cell death in liver cancer cells.
Son SH; Yu E; Choi EK; Lee H; Choi J
Cancer Gene Ther; 2005 Jan; 12(1):1-11. PubMed ID: 15529177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
